Optimal Assessment and Therapy for Patients with Spasticity: Considerations for Effective Treatment
| Title: | Optimal Assessment and Therapy for Patients with Spasticity: Considerations for Effective Treatment |
| Topic: | Neurology |
| Relevant Terms: | Spasticity |
| Primary Audience: | Neurologists, physiatrists |
| Launch Date: | 22-Oct-12 |
| Credits: | 0.5 AMA PRA Category 1 Credit™ |
| Expiration Date: | 22-Oct-13 |
| Curriculum Name: | Optimal Assessment and Therapy for Patients with Spasticity |
Learning Objectives
After completing this activity, the participant will demonstrate the ability to:
- Discuss how to individually assess patients with spasticity to better implement strategies for management of their symptoms.
- Determine when botulinum neurotoxin therapy may best benefit patients with spasticity.
- Incorporate effective and safe dosing and administration strategies, including appropriate muscle selection, for botulinum neurotoxins in patients with spasticity.
Faculty
Zoltan Mari, MD
Assistant Professor of Neurology
Director, Movement Disorder Fellowship Training Program
Director, Dystonia and Chemodenervation Center
Director, National Parkinson Foundation Center of Excellence
Director, Deep Brain Stimulation Center
Johns Hopkins University
Baltimore, MD
Elizabeth Ann Moberg-Wolff, MD, FAAPMR
Medical Director
Pediatric Rehabilitation Medicine Associates, LLC
Brookfield, WI
Assistant Professor of Neurology
Director, Movement Disorder Fellowship Training Program
Director, Dystonia and Chemodenervation Center
Director, National Parkinson Foundation Center of Excellence
Director, Deep Brain Stimulation Center
Johns Hopkins University
Baltimore, MD
Elizabeth Ann Moberg-Wolff, MD, FAAPMRMedical Director
Pediatric Rehabilitation Medicine Associates, LLC
Brookfield, WI
PLANNERS AND REVIEWERS DISCLOSURE
Dr. Mari discloses that he has acted as a consultant for Medtronic, has participated on the advisory boards of Merz, US WorldMeds, and Ipsen, and has received grant funding from Allergan and Merz.
Dr. Moberg-Wolff discloses that she has served as a consultant for CNS Therapeutics and on the speakers bureau for US WorldMeds.
Rick Ricer, MD, physician reviewer, has no conflicts of interest to disclose.
Susan P. Tyler, MEd, CCMEP, FACEHP, has no conflicts of interest to disclose.
Elizabeth Friedenwald, MCM Education medical writer, has no conflicts of interest to disclose.
Kathleen Hines, MCM Education associate editorial director, has no conflicts of interest to disclose.
Dr. Mari discloses that he has acted as a consultant for Medtronic, has participated on the advisory boards of Merz, US WorldMeds, and Ipsen, and has received grant funding from Allergan and Merz.
Dr. Moberg-Wolff discloses that she has served as a consultant for CNS Therapeutics and on the speakers bureau for US WorldMeds.
Rick Ricer, MD, physician reviewer, has no conflicts of interest to disclose.
Susan P. Tyler, MEd, CCMEP, FACEHP, has no conflicts of interest to disclose.
Elizabeth Friedenwald, MCM Education medical writer, has no conflicts of interest to disclose.
Kathleen Hines, MCM Education associate editorial director, has no conflicts of interest to disclose.
DISCLAIMER
The opinions or views expressed in this CME activity are those of the presenters and do not necessarily reflect the opinions or recommendations of the University of Cincinnati, MCM Education, or the commercial supporter(s). Participants should critically appraise the information presented and are encouraged to consult appropriate resources for information surrounding any product, device, or procedure mentioned.
ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the Essentials Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Cincinnati and MCM Education. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.
ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the Essentials Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Cincinnati and MCM Education. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.
CREDIT DESIGNATION
The University of Cincinnati designates this Enduring Material Activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
University of Cincinnati
Continuing Medical Education
College of Medicine
3225 Eden Avenue, G24 Wherry Hall
Cincinnati, OH 45267
Phone: 513-558-3132
University of Cincinnati
Continuing Medical Education
College of Medicine
3225 Eden Avenue, G24 Wherry Hall
Cincinnati, OH 45267
Phone: 513-558-3132
Release Date: October 22, 2012
Expiration Date: October 22, 2013
TERM OF OFFERING
This activity has a release date of October 22, 2012 and is valid for 1 year. Requests for credit must be received no later than October 22, 2013.
CREDIT DETERMINATION
A review committee has agreed that this material can be completed in 30 minutes. This estimated study time in turn has determined the credit hours being offered.
INSTRUCTIONS FOR PARTICIPATING IN THIS ACTIVITY AND OBTAINING CME CREDIT
There are no fees for participating in and receiving CME credit for this online educational activity. By reviewing the course content and successfully completing the post-test and evaluation, clinicians are entitled to receive credit. The statement of credit will be available to print from your user history page.
- Read the learning objectives and faculty disclosures
- Participate in the activity
- Complete the post-test and activity evaluation
- Clinicians who successfully complete the post-test and evaluation will receive a CME certificate; successful completion is defined as a cumulative score of at least 80% correct
- All other participants who successfully complete the post-test and evaluation will receive a certificate of participation
ESTIMATED TIME TO COMPLETE
30 minutes
VIEWING REQUIREMENTS
PC
Internet Explorer (v7 or greater), Google Chrome, or Firefox
Mac
Safari, Google Chrome, or Firefox
COMMERCIAL SUPPORT
This activity is supported by an independent educational grant from Allergan, Inc.
Commercial Support Guidelines
If any activity is supported by funds from a commercial source such as a pharmaceutical company or an equipment manufacturer it is very important that the Standards for Commercial Support are followed. In general, commercial entities may support CME activities through unrestricted grants. A commercial supporter may not exert undue influence in the form of determining content, choosing speakers, directly paying honoraria to faculty or paying registration fees of attendees. An acknowledgement of any educational support from a commercial company must appear in program brochures, syllabi, and other program materials.
PC
Internet Explorer (v7 or greater), Google Chrome, or Firefox
Mac
Safari, Google Chrome, or Firefox
COMMERCIAL SUPPORT
This activity is supported by an independent educational grant from Allergan, Inc.
Commercial Support Guidelines
If any activity is supported by funds from a commercial source such as a pharmaceutical company or an equipment manufacturer it is very important that the Standards for Commercial Support are followed. In general, commercial entities may support CME activities through unrestricted grants. A commercial supporter may not exert undue influence in the form of determining content, choosing speakers, directly paying honoraria to faculty or paying registration fees of attendees. An acknowledgement of any educational support from a commercial company must appear in program brochures, syllabi, and other program materials.
